Literature DB >> 15301933

Altered sleep latency and arousal regulation in mice lacking norepinephrine.

Melissa S Hunsley1, Richard D Palmiter.   

Abstract

Latency to sleep and the amount of sensory stimulation required to awaken an animal are measures of arousal threshold, which are ultimately modulated by an arousal regulation system involving many brain areas. Among these brain areas and network connections are wake-promoting nuclei of the brainstem and their corresponding neurotransmitters, including norepinephrine (NE). In this study, we used mice that are unable to produce NE to study its role in regulating sleep latency after a variety of interventions, and to study arousal from sleep after sleep deprivation (SD). Sleep latency was measured after gentle awakening or after injections of saline, caffeine or modafinil. Sleep latency was also measured before and after partial restoration of NE pharmacologically. Arousal threshold was measured by recording the number of decibels of white noise required to wake each mouse from NREM sleep after 0, 3 and 3 + 3 h SD (3 h SD followed by < 2 min sleep, followed by an additional 3 h SD). Results showed that when mice were awakened without being touched, there were no differences in sleep latency between the genotypes. However, after an injection of saline, the control mice increased their sleep latency, whereas the NE-deficient mice did not. There were no group differences in sleep latency after treatment with either stimulant. The sleep latency difference between the genotypes was ameliorated by partial restoration of NE. The arousal threshold experiments revealed that significantly more noise was required to wake the NE-deficient mice after 3 and 3 + 3 h of SD. These findings show that mice lacking NE fall asleep more rapidly only after a mild stressor, such as an intraperitoneal injection. NE-deficient mice are also more difficult to wake up using audio stimulation after SD. The results presented here suggest that NE promotes wakefulness during transitions between sleep and wake under conditions involving mild stress and SD, but not under baseline circumstances. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15301933     DOI: 10.1016/j.pbb.2004.05.008

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  19 in total

1.  Persistence of circadian variation in arterial blood pressure in beta1/beta2-adrenergic receptor-deficient mice.

Authors:  Soo Mi Kim; Yuning Huang; Yan Qin; Diane Mizel; Jurgen Schnermann; Josephine P Briggs
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-02-27       Impact factor: 3.619

Review 2.  Behavioral phenotyping of mouse models of Parkinson's disease.

Authors:  Tonya N Taylor; James G Greene; Gary W Miller
Journal:  Behav Brain Res       Date:  2010-03-06       Impact factor: 3.332

Review 3.  Mammalian sleep genetics.

Authors:  Jessica M Kelly; Matt T Bianchi
Journal:  Neurogenetics       Date:  2012-09-14       Impact factor: 2.660

4.  Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.

Authors:  Laura M Butkovich; Madelyn C Houser; Termpanit Chalermpalanupap; Kirsten A Porter-Stransky; Alexa F Iannitelli; Jake S Boles; Grace M Lloyd; Alexandra S Coomes; Lori N Eidson; Maria Elizabeth De Sousa Rodrigues; Danielle L Oliver; Sean D Kelly; Jianjun Chang; Nora Bengoa-Vergniory; Richard Wade-Martins; Benoit I Giasson; Valerie Joers; David Weinshenker; Malú Gámez Tansey
Journal:  J Neurosci       Date:  2020-08-31       Impact factor: 6.167

5.  Vulnerability to insomnia: the role of familial aggregation.

Authors:  Christopher L Drake; Holly Scofield; Thomas Roth
Journal:  Sleep Med       Date:  2007-09-06       Impact factor: 3.492

Review 6.  Good night and good luck: norepinephrine in sleep pharmacology.

Authors:  Heather A Mitchell; David Weinshenker
Journal:  Biochem Pharmacol       Date:  2009-10-13       Impact factor: 5.858

Review 7.  Biological rhythms, higher brain function, and behavior: Gaps, opportunities, and challenges.

Authors:  Ruth Benca; Marilyn J Duncan; Ellen Frank; Colleen McClung; Randy J Nelson; Aleksandra Vicentic
Journal:  Brain Res Rev       Date:  2009-09-18

8.  The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents.

Authors:  John A Gruner; Val R Marcy; Yin-Guo Lin; Donna Bozyczko-Coyne; Michael J Marino; Maciej Gasior
Journal:  Sleep       Date:  2009-11       Impact factor: 5.849

9.  Behavioral responses of dopamine beta-hydroxylase knockout mice to modafinil suggest a dual noradrenergic-dopaminergic mechanism of action.

Authors:  Heather A Mitchell; James W Bogenpohl; L Cameron Liles; Michael P Epstein; Donna Bozyczko-Coyne; Michael Williams; David Weinshenker
Journal:  Pharmacol Biochem Behav       Date:  2008-07-25       Impact factor: 3.533

10.  Narcolepsy-like sleep disturbance in orexin knockout mice are normalized by the 5-HT1A receptor agonist 8-OH-DPAT.

Authors:  Tomohisa Mori; Naoki Uzawa; Yoshiyuki Iwase; Daiki Masukawa; Mahardian Rahmadi; Shigeto Hirayama; Mayuna Hokazono; Kimio Higashiyama; Seiji Shioda; Tsutomu Suzuki
Journal:  Psychopharmacology (Berl)       Date:  2016-04-11       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.